Polaryx Therapeutics, Inc
Price
FilingsNewest: 8-K, Shareholder voteSep 11 →Insiders3 insiders bought $368,003 in 2 open-market buys. No sales.→HoldersVanguard 3.3%Geode 0.3%Vanguard Fiduciary Trust 0.2%→Financing →PeersClosest companies: TRDA, IRD, DYN→
From the filings
Figures
- Net income
- −$6.5Mlast 12 months
- Operating cash flow
- −$5.3Mlast 12 months
- Cash and equivalents
- $11.5Mat the last balance sheet
- Shares outstanding
- 49.8M shareson issue